Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06029907 · ClinicalTrials.gov registry record · Phase 4
Project HOPES: Healthy Options for Pain and Ending Smoking. A Program for Cancer Survivors.
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT06029907 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 19 participants.
The verdict
NCT06029907, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
The proposed pilot study will develop and test feasibility, acceptability, and signal for efficacy of a smoking cessation and pain management intervention for 20 cancer survivors.
Interventions
- DRUG Varenicline
- OTHER Smoking cessation and pain management intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2024-07-15 |
| Est. Completion | 2025-08-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06029907
The ClinicalTrials.gov registry entry for NCT06029907 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Varenicline is the first listed.
NCT06029907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06029907 about?
NCT06029907 is a clinical study titled "Project HOPES: Healthy Options for Pain and Ending Smoking. A Program for Cancer Survivors.". The proposed pilot study will develop and test feasibility, acceptability, and signal for efficacy of a smoking cessation and pain management intervention for 20 cancer survivors.
What is the current status of trial NCT06029907?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2024-07-15. Estimated completion is 2025-08-29.
What interventions are being tested in trial NCT06029907?
The interventions under investigation include: Varenicline (DRUG), Smoking cessation and pain management intervention (OTHER).
Who is sponsoring clinical trial NCT06029907?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.